Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefTags

From GxPlex

Jump to: navigation, search

Text

Raw TAG-ID list for this reference (used for glossary queries).

previous 202050100250500next 20
Showing 20 pages using this property.
U
USA 21 CFR Part 812 09-Apr-2025 § 812.110 (c) +
TAG-00246-Inv-hte ++ TAG-00202-Inv-Pro ++ TAG-00155-Med-Med ++ TAG-00092-Dru-nte  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-001 +
TAG-00246-Inv-hte ++ TAG-00245-Spo-ten ++ TAG-00057-Com-deR ++ TAG-00001-Med-rzn  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-002 +
TAG-00246-Inv-hte ++ TAG-00245-Spo-ten ++ TAG-00057-Com-deR ++ TAG-00001-Med-rzn  +
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40d-003 +
TAG-00246-Inv-hte ++ TAG-00245-Spo-ten ++ TAG-00057-Com-deR ++ TAG-00001-Med-rzn  +
U
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. A. +
TAG-00246-Inv-hte ++ TAG-00248-Inv-die ++ TAG-00329-Saf-lne ++ TAG-00320-Foo-eri ++ TAG-00001-Med-rzn  +
USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (4) +
TAG-00246-Inv-hte ++ TAG-00320-Foo-eri ++ TAG-00134-Eth-kom ++ TAG-00155-Med-Med ++ TAG-00111-Agr-chr  +
USA 21 CFR Part 312 09-Apr-2025 § 312.60-001 +
TAG-00246-Inv-hte ++ TAG-00329-Saf-lne ++ TAG-00018-Inv-die ++ TAG-00320-Foo-eri  +
USA 21 CFR Part 812 09-Apr-2025 § 812.100 +
TAG-00246-Inv-hte ++ TAG-00329-Saf-lne ++ TAG-00155-Med-Med ++ TAG-00320-Foo-eri  +
USA 21 CFR Part 312 09-Apr-2025 § 312.60-002 +
TAG-00246-Inv-hte ++ TAG-00329-Saf-lne ++ TAG-00025-Sub-mer ++ TAG-00320-Foo-eri  +
USA 21 CFR Part 812 09-Apr-2025 Subpart E +
TAG-00246-Inv-hte ++ TAG-00329-Saf-lne ++ TAG-00320-Foo-eri ++ TAG-00155-Med-Med  +
I
ICH ICH E6 Guideline - Annex 2 R3 Annex 2 Annex 2 2.4 - 2.5 +
TAG-00248-Inv-die ++ TAG-00329-Saf-lne ++ TAG-00250-Inv-sme ++ TAG-00025-Sub-mer  +
U
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B. +
TAG-00248-Inv-die ++ TAG-00329-Saf-lne ++ TAG-00025-Sub-mer ++ TAG-00320-Foo-eri  +
I
ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.8 +
TAG-00250-Inv-sme ++ TAG-00019-Pri-Prü ++ TAG-00213-Ser-wie ++ TAG-00208-Dev-ers ++ TAG-00017-Spo-die  +
U
USA 21 CFR Part 812 09-Apr-2025 § 812.150 (a) (5) +
TAG-00250-Inv-sme ++ TAG-00029-Inf-rte ++ TAG-00017-Spo-die ++ TAG-00155-Med-Med ++ TAG-00320-Foo-eri  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-001 +
TAG-00250-Inv-sme ++ TAG-00045-Adv-hte ++ TAG-00046-Ser-sSc ++ TAG-00017-Spo-die ++ TAG-00033-Pro-oto  +
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 41-002 +
TAG-00250-Inv-sme ++ TAG-00045-Adv-hte ++ TAG-00046-Ser-sSc ++ TAG-00017-Spo-die ++ TAG-00033-Pro-oto  +
D
DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 63 +
TAG-00250-Inv-sme ++ TAG-00046-Ser-sSc ++ TAG-00018-Inv-die ++ TAG-00019-Pri-Prü ++ TAG-00017-Spo-die  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 32 +
TAG-00250-Inv-sme ++ TAG-00046-Ser-sSc ++ TAG-00017-Spo-die ++ TAG-00135-Inv-ntr  +
GBR Directive 2001/20/EC 04-Apr-2001 Article 16 +
TAG-00250-Inv-sme ++ TAG-00046-Ser-sSc ++ TAG-00017-Spo-die ++ TAG-00034-Inv-Bro ++ TAG-00033-Pro-oto  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.64 (b) +
TAG-00250-Inv-sme ++ TAG-00046-Ser-sSc ++ TAG-00329-Saf-lne ++ TAG-00066-Cau-enh ++ TAG-00320-Foo-eri  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefTags&oldid=20452"